drugset / Trial / NCT07135089

Improving Neuroprotective Strategy for Ischemic Stroke Before Endovascular Thrombectomy by Intravenous Tirofiban

NCT07135089

Phase 3 Recruiting 870 enrolled General Hospital of Shenyang Military Region
RandomizedParallel-groupQuadruple-blindTreatment

Summary

It remains uncertain whether intravenous tirofiban administered before endovascular thrombectomy could improve disability severity for patients with LVO due to intracranial atherosclerosis.The current study aimed to assess the efficacy and safety of administering intravenous tirofiban before endovascular thrombectomy for improving clinical outcomes in patients with anterior circulation LVO due to intracranial atherosclerosis.

Timeline

Start
2025-11-13
Primary completion
2027-09-30
Completion
2027-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Tirofiban Other / unclassified 0.15 ug/kg Intravenous

Indications